These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37435446)

  • 1. Low but not undetectable early postoperative nadir serum cortisol predicts sustained remission in Cushing's disease.
    Stroud A; Dhaliwal P; Harvey RJ; Alvarado R; Jonker BP; Winder MJ; Grayson JW; McCormack A
    Endocr Oncol; 2022 Jan; 2(1):19-31. PubMed ID: 37435446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of pituitary surgery for Cushing's disease: a systematic review and meta-analysis.
    Stroud A; Dhaliwal P; Alvarado R; Winder MJ; Jonker BP; Grayson JW; Hamizan A; Harvey RJ; McCormack A
    Pituitary; 2020 Oct; 23(5):595-609. PubMed ID: 32691356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.
    Yap LB; Turner HE; Adams CB; Wass JA
    Clin Endocrinol (Oxf); 2002 Jan; 56(1):25-31. PubMed ID: 11849243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low immediate postoperative serum-cortisol nadir predicts the short-term, but not long-term, remission after pituitary surgery for Cushing's disease.
    Ramm-Pettersen J; Halvorsen H; Evang JA; Rønning P; Hol PK; Bollerslev J; Berg-Johnsen J; Helseth E
    BMC Endocr Disord; 2015 Oct; 15():62. PubMed ID: 26499317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing's disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience.
    Hameed N; Yedinak CG; Brzana J; Gultekin SH; Coppa ND; Dogan A; Delashaw JB; Fleseriu M
    Pituitary; 2013 Dec; 16(4):452-8. PubMed ID: 23242860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative metyrapone test in the early assessment of outcome of pituitary surgery for Cushing's disease.
    van Aken MO; de Herder WW; van der Lely AJ; de Jong FH; Lamberts SW
    Clin Endocrinol (Oxf); 1997 Aug; 47(2):145-9. PubMed ID: 9302385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease.
    Acebes JJ; Martino J; Masuet C; Montanya E; Soler J
    Acta Neurochir (Wien); 2007; 149(5):471-7; discussion 477-9. PubMed ID: 17406780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
    Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment.
    Trainer PJ; Lawrie HS; Verhelst J; Howlett TA; Lowe DG; Grossman AB; Savage MO; Afshar F; Besser GM
    Clin Endocrinol (Oxf); 1993 Jan; 38(1):73-8. PubMed ID: 8435888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of Late-Night Salivary Cortisol in Evaluating Postoperative Remission and Recurrence in Cushing's Disease.
    Amlashi FG; Swearingen B; Faje AT; Nachtigall LB; Miller KK; Klibanski A; Biller BM; Tritos NA
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3770-7. PubMed ID: 26196950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative plasma cortisol levels predict long-term outcome in patients with Cushing's disease and determine which patients should be treated with pituitary irradiation after surgery.
    Imaki T; Tsushima T; Hizuka N; Odagiri E; Murata Y; Suda T; Takano K
    Endocr J; 2001 Feb; 48(1):53-62. PubMed ID: 11403103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of endoscopic transsphenoidal surgery for Cushing's disease.
    Brady Z; Garrahy A; Carthy C; O'Reilly MW; Thompson CJ; Sherlock M; Agha A; Javadpour M
    BMC Endocr Disord; 2021 Mar; 21(1):36. PubMed ID: 33658018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of the desmopressin test in the postoperative evaluation of patients with Cushing's disease.
    Colombo P; Dall'Asta C; Barbetta L; Re T; Passini E; Faglia G; Ambrosi B
    Eur J Endocrinol; 2000 Aug; 143(2):227-34. PubMed ID: 10913942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic usefulness of ACTH in the postoperative period of Cushing's disease.
    Abellán-Galiana P; Fajardo-Montañana C; Riesgo-Suárez P; Pérez-Bermejo M; Ríos-Pérez C; Gómez-Vela J
    Endocr Connect; 2019 Sep; 8(9):1262-1272. PubMed ID: 31394502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of Immediate Remission after Surgery in Cushing's Disease Patients: A Large Retrospective Study from a Single Center.
    Dai C; Fan Y; Liu X; Bao X; Yao Y; Wang R; Feng M
    Neuroendocrinology; 2021; 111(11):1141-1150. PubMed ID: 32512562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Cushing's disease remission after transsphenoidal surgery based on early serum cortisol dynamics.
    Costenaro F; Rodrigues TC; Rollin GA; Ferreira NP; Czepielewski MA
    Clin Endocrinol (Oxf); 2014 Mar; 80(3):411-8. PubMed ID: 23895112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting relapse after transsphenoidal surgery for Cushing's disease.
    Toms GC; McCarthy MI; Niven MJ; Orteu CH; King TT; Monson JP
    J Clin Endocrinol Metab; 1993 Feb; 76(2):291-4. PubMed ID: 8432771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical review: Early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing's disease.
    Esposito F; Dusick JR; Cohan P; Moftakhar P; McArthur D; Wang C; Swerdloff RS; Kelly DF
    J Clin Endocrinol Metab; 2006 Jan; 91(1):7-13. PubMed ID: 16234305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comprehensive Approach to Predicting the Outcomes of Transsphenoidal Endoscopic Adenomectomy in Patients with Cushing's Disease.
    Kuritsyna NV; Tsoy UA; Cherebillo VY; Paltsev AA; Ryzhkov AV; Ryazanov PA; Ryzhkov VK; Grineva EN
    J Pers Med; 2022 May; 12(5):. PubMed ID: 35629220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease.
    Flitsch J; Knappe UJ; Lüdecke DK
    Zentralbl Neurochir; 2003; 64(1):6-11. PubMed ID: 12582940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.